In papillary thyroid cancers the ETS variant 5 (ETV5) is abundantly expressed and able to activate mutant TERT promoter in GABP-negative thyroid cancer cells (Chun-On et al., 2022). This evidence concerns the gene ETV5 and thyroid gland papillary carcinoma.